Key result
Structured education boosts healthcare provider knowledge scores on PCSK9 inhibitors by ~52%.
Why the study?
Does a structured educational intervention improve knowledge, attitudes, and prescribing perceptions regarding PCSK9 inhibitors among healthcare professionals?
Does a structured educational intervention improve knowledge, attitudes, and prescribing perceptions regarding PCSK9 inhibitors among healthcare professionals?
Answers are grounded in this paper and cite their sources.
A structured educational intervention significantly enhances healthcare professionals' knowledge, attitudes, and prescribing confidence regarding PCSK9 inhibitors.
Background: Proprotein convertase subtilisin/kexin type 9 inhibitors have shown significant efficacy in lipid management for high-risk patients with poor control of LDL-C levels. Although there is considerable evidence of the efficacy of PCSK9 inhibitors, there has been limited use of these drugs in Saudi Arabia. Objective: The current study aimed to assess the impact of a structured educational intervention on the KAP of PCSK9 inhibitors among HCPs. Methods: A quasi-experimental pre-post interventional study was conducted among 150 physicians and pharmacists in two tertiary care hospitals in Saudi Arabia. Participants completed a validated knowledge, attitudes, and prescribing perceptions questionnaire before and three months after a structured educational intervention. Pre–post differences were analysed using paired-samples t-tests. Results: A total of 150 HCPs completed both assessments. Significant improvements were observed across all domains following the intervention. Mean knowledge scores increased from 3.31 ± 1.18 to 5.02 ± 0.91 (p < 0.001), attitudes improved from 3.21 ± 0.82 to 4.38 ± 0.64 (p < 0.001), and prescribing perceptions increased from 2.79 ± 0.91 to 4.26 ± 0.72 (p < 0.001). All domains demonstrated large effect sizes (Cohen’s d > 0.8), indicating clinically meaningful improvements. Agreement regarding the effectiveness of PCSK9 inhibitors increased (62% to 88%), while perceived barriers such as cost and access declined, although not completely resolved. Improvements were consistent across professions and institutions. Conclusion: Structured educational interventions significantly enhance HCP knowledge, attitudes, and prescribing confidence regarding PCSK9 inhibitors. However, persistent system-level barriers highlight the need for complementary policy and access-related strategies to optimise their utilisation in clinical practice.
No takes yet. Share an insight, caveat, or question.
Yasir Awad Ahmed (2026) studied Knowledge, attitudes, and prescribing perceptions regarding PCSK9 inhibitors (n=150). Structured educational intervention vs. Pre-intervention baseline was evaluated on Mean knowledge scores (Cohen's d > 0.8, p=<0.001). A structured educational intervention improved healthcare professionals' mean knowledge scores regarding PCSK9 inhibitors from 3.31 to 5.02.
Synapse has enriched 10 related papers. Consider them for comparative context: